drugset / Trial / NCT01830296

Intravenous Remifentanil Plus Morphine or Morphine Alone for Postthoracotomy Pain

NCT01830296 ↗

Phase 4 Completed 60 enrolled Cukurova University
RandomizedCrossoverDouble-blindTreatment

Summary

Background; Post-thoracotomy pain remains a major problem. This double-blind, randomized study tested the effects of coadministration of patient controlled remifentanil+morphine combination on postthoracotomy pain, analgesic consumption and side effects compared with morphine PCA alone

Timeline

Start
2011-05
Primary completion
2012-10
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 0.2 mg/kg Intravenous
Comparator Remifentanil Small molecule 0.2 ug/kg Intravenous

Indications

No indication recorded.